SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001159036-20-000012
Filing Date
2020-02-24
Accepted
2020-02-24 16:09:45
Documents
14
Period of Report
2020-02-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K cfotransition.htm   iXBRL 8-K 46378
  Complete submission text file 0001159036-20-000012.txt   189913

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20200218.xsd EX-101.SCH 4582
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20200218_cal.xml EX-101.CAL 620
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20200218_def.xml EX-101.DEF 1470
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20200218_lab.xml EX-101.LAB 26142
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20200218_pre.xml EX-101.PRE 13576
8 EXTRACTED XBRL INSTANCE DOCUMENT cfotransition_htm.xml XML 4286
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 20644384
SIC: 2836 Biological Products, (No Diagnostic Substances)